NASDAQ: ZSQRZ Squared Inc Stock
$15.03-0.17 (-1.12%)
Updated Apr 28, 2026
ZSQR Price
$15.03
Fair Value Price
$1.28
Market Cap
$93.50M
52 Week Low
$6.80
52 Week High
$21.41
P/E
-5.35x
P/B
6.89x
P/S
44.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.36M
Earnings
-$11.92M
Gross Margin
86.7%
Operating Margin
-867.2%
Profit Margin
-874.3%
Debt to Equity
0.15
Operating Cash Flow
-$9M
Beta
0.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ZSQR Overview
Operates as a digital asset mining company
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZSQR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ZSQR news, forecast changes, insider trades & much more!
ZSQR News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZSQR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZSQR ($15.03) is overvalued by 1,077.11% relative to our estimate of its Fair Value price of $1.28 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ZSQR ($15.03) is not significantly undervalued (1,077.11%) relative to our estimate of its Fair Value price of $1.28 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ZSQR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZSQR due diligence checks available for Premium users.
Valuation
ZSQR fair value
Fair Value of ZSQR stock based on Discounted Cash Flow (DCF)
Price
$15.03
Fair Value
$1.28
Overvalued by
1,077.50%
ZSQR ($15.03) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZSQR ($15.03) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZSQR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ZSQR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.35x
Industry
21.42x
Market
31.26x
ZSQR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.89x
Industry
4.88x
ZSQR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZSQR's financial health
Profit margin
Revenue
$862.0k
Net Income
-$1.6M
Profit Margin
-183%
ZSQR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZSQR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.2M
Liabilities
$2.1M
Debt to equity
0.15
ZSQR's short-term assets ($7.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZSQR's short-term assets ($7.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZSQR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZSQR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.7M
Investing
$0.0
Financing
$2.5M
ZSQR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZSQR vs Biotech Stocks
Z Squared Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.